Department of Plastic and Reconstructive Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Department of Plastic and Reconstructive Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-Gu, Seoul, 137-701, Republic of Korea.
Tissue Eng Regen Med. 2024 Aug;21(6):829-842. doi: 10.1007/s13770-024-00644-2. Epub 2024 Apr 22.
In this study, we explored the potential of human adipose tissue-derived extracellular matrix (adECM) sheets augmented with crosslinked hyaluronic acid (HA) as advanced wound dressings. We aimed to enhance healing efficacy while optimizing cost efficiency.
The adECM was processed from healthy donor tissue and combined with crosslinked HA to form ECM-HA sheets (Scaffiller, Medikan, Korea). In vitro experiments involved seeding adipose-derived stem cells (ASCs) onto these sheets and assessing cell survival and cytokine production. In vivo testing utilized a rat wound model, comparing ECM-HA sheet with HA-based dressing and polyurethane foam dressing. Re-epithelialization and collagen deposition were examined through histopathological examinations, whereas immunohistochemistry was used to assess CD31, alpha smooth muscle actin (α-SMA), and Tenascin C expression as contributing factors to wound healing.
Results indicated that ECM-HA sheets were produced efficiently, with enhanced growth factor production and ASC survival observed in vitro. In vivo, ECM-HA sheets demonstrated accelerated wound healing, evidenced by improved epithelialization, thicker dermis, increased collagen deposition, and enhanced vascularity. Notably, they exhibited reduced myofibroblast activity and increased expression of Tenascin C, suggesting a favorable healing environment.
ECM-HA sheets offer a promising approach for wound management, combining the benefits of adECM and HA. They present improved stability and cost-effectiveness while promoting essential aspects of wound healing such as angiogenesis and collagen formation. This study underscores the therapeutic potential of ECM-HA sheets in clinical applications aimed at facilitating wound repair.
本研究探索了交联透明质酸(HA)增强的人脂肪组织衍生细胞外基质(adECM)片作为先进伤口敷料的潜力。我们旨在提高治疗效果的同时优化成本效益。
adECM 从健康供体组织中提取,与交联 HA 结合形成 ECM-HA 片(Scaffiller,Medikan,韩国)。体外实验包括将脂肪源性干细胞(ASCs)接种到这些片上,并评估细胞存活和细胞因子产生。体内试验采用大鼠伤口模型,比较 ECM-HA 片与基于 HA 的敷料和聚氨酯泡沫敷料。通过组织病理学检查评估再上皮化和胶原沉积,免疫组织化学用于评估 CD31、α 平滑肌肌动蛋白(α-SMA)和 Tenascin C 的表达,作为促进伤口愈合的因素。
结果表明,ECM-HA 片的产量很高,体外观察到生长因子产生和 ASC 存活增加。体内,ECM-HA 片表现出加速的伤口愈合,表现为上皮化改善、真皮增厚、胶原沉积增加和血管生成增强。值得注意的是,它们表现出减少的肌成纤维细胞活性和增加的 Tenascin C 表达,表明有一个有利的愈合环境。
ECM-HA 片为伤口管理提供了一种有前途的方法,结合了 adECM 和 HA 的优势。它们具有更好的稳定性和成本效益,同时促进了血管生成和胶原形成等伤口愈合的重要方面。本研究强调了 ECM-HA 片在以促进伤口修复为目标的临床应用中的治疗潜力。